Iterative Hepatic and Pulmonary Metastasectomy in Stage IV Colorectal Cancer: Impact on Survival and Surgical Outcomes
Our data suggest comparable benefits from hepatic metastasectomy regardless of metastatic sequence. Our findings demonstrate the safety and potential survival benefits of iterative hepatic and pulmonary resections for recurrent colorectal cancer metastases. These data support an aggressive surgical approach in selected patients with recurrent colorectal metastases.
Authors
- Hans Christian Hillebrecht (ORCID: https://orcid.org/0000-0003-1696-3250)
- Rebecca Kesselring (ORCID: https://orcid.org/0000-0001-8131-7605)
- Philipp Holzner (ORCID: https://orcid.org/0000-0001-9221-9728)
- Uyen‐Thao Le (ORCID: https://orcid.org/0000-0002-5671-3048)
- Christopher Berlin (ORCID: https://orcid.org/0000-0001-9727-1533)
- M. Menzel (ORCID: https://orcid.org/0000-0002-2938-1228)
- Francesca Reimer
- Guillermo Stöger (ORCID: https://orcid.org/0000-0002-5407-705X)
- Stefan Fichtner‐Feigl (ORCID: https://orcid.org/0000-0002-6710-562X)
- Luisa Schäfer (ORCID: https://orcid.org/0000-0002-7044-6222)
- Andreas Gengenbach
Institutions
- University of Freiburg (DE)
- German Cancer Research Center (DE)
- University Medical Center Freiburg (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-09-30
- DOI
- https://doi.org/10.1245/s10434-025-18407-1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00